These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18042585)

  • 1. Atherosclerosis and lupus: the SLICC Study.
    Urowitz MB; Gladman DD
    Lupus; 2007; 16(12):925-8. PubMed ID: 18042585
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
    Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.
    Westerweel PE; Luyten RK; Koomans HA; Derksen RH; Verhaar MC
    Arthritis Rheum; 2007 May; 56(5):1384-96. PubMed ID: 17469095
    [No Abstract]   [Full Text] [Related]  

  • 5. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Haque S; Mirjafari H; Bruce IN
    Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes in systemic lupus erythematosus: big studies for big questions.
    Haque S; Bruce IN
    J Rheumatol; 2009 Mar; 36(3):467-9. PubMed ID: 19286857
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular risk assessment and treatment in systemic lupus erythematosus.
    Elliott JR; Manzi S
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):481-94. PubMed ID: 19591779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SLICC inception cohort for atherosclerosis.
    Urowitz MB; Gladman DD
    Curr Rheumatol Rep; 2008 Aug; 10(4):281-5. PubMed ID: 18662507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical atherosclerosis in systemic lupus erythematosus.
    Ahmad Y; Bruce IN
    J Rheumatol; 2004 May; 31(5):841-3. PubMed ID: 15124239
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for accelerated atherosclerosis in patients with systemic lupus erythematosus.
    Marasini B; De Monti M; Ghilardi G
    Ann Rheum Dis; 2005 Jan; 64(1):163-4. PubMed ID: 15608323
    [No Abstract]   [Full Text] [Related]  

  • 12. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort.
    Durán S; González LA; Alarcón GS
    J Clin Rheumatol; 2007 Dec; 13(6):350-3. PubMed ID: 18176147
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventive strategies in systemic lupus erythematosus.
    Doria A; Arienti S; Rampudda M; Canova M; Tonon M; Sarzi-Puttini P
    Autoimmun Rev; 2008 Jan; 7(3):192-7. PubMed ID: 18190877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis and lupus: what we know and what we should know.
    Doria A
    J Rheumatol; 2009 Nov; 36(11):2380-2. PubMed ID: 19893058
    [No Abstract]   [Full Text] [Related]  

  • 15. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.
    Shang Q; Tam LS; Li EK; Yip GW; Yu CM
    Lupus; 2008 Dec; 17(12):1096-102. PubMed ID: 19029277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
    Ayoub S; Hickey MJ; Morand EF
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):98-105. PubMed ID: 18235539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus-related atherosclerosis: a novel target for treatment?
    Shovman O; Gilburd B; Shoenfeld Y
    J Rheumatol; 2006 Mar; 33(3):445-7. PubMed ID: 16511912
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular manifestations of systemic lupus erythematosus].
    Gómez-León Mandujano A; Amezcua-Guerra LM
    Arch Cardiol Mex; 2008; 78(4):421-30. PubMed ID: 19205552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.